Maria A. Miteva
  • E-mail :[email]
  • Phone : +331 70649403
  • Location : Pharmacie de Paris, France
Last update 2021-01-11 14:39:19.119

Maria A. Miteva PhD, HDR

Course and current status

2019 - Research Director at Inserm  & Co-director Inserm U1268 MCTR ( UMR 8038 CNRS - Univ. Paris)

2013- 2018: Research Director at Inserm  & Group Leader "Virtual screening, PPI & ADMET in silico") (Inserm U973 MTi)

2012 - 2016: Member of the Inserm commission CSS1

Since 2009: Expert for EU FP7, H2020, French ANR

Since 2009: Senior researcher at MTI, Inserm U973 -Univ. Paris Diderot (CR1 –HDR)

2005–2008: Senior researcher (CR1) (in silico drug design , chemoinformatics, virtual screening, ADMET) Inserm Unit 648, Univ.Paris 5

2002–2005: Visiting scientist postdoc (biostructural pathology - human mutations) («poste vert-chercheur etranger»), Inserm Unit 428, Univ.Paris 5

2001-2002: Visiting scientist postdoc («chercheur associé») (molecular dynamics, protein-protein interactions), Lab. MIP, CNRS, Univ.Paris-Sud, Orsay, France

1997,1998: Visiting scientist (protein electrostatics; proteins in gas phase), Karolinska Institute, NOVUM, Huddinge, Sweden

1993–2001: Scientific researcher (structural bioinformatics, force fields), Institute of Organic Chemistry, Bulgarian Academy of Sciences

1991-1993: Engineer of Biotechnics (development of scientific software), Institute of Organic Chemistry, Bulgarian Academy of Sciences, Sofia

Scientific summary

Research topics 

Bio/Chemo-informatics, protein science, biophysical chemistry, electrostatics, force fields, medicinal chemistry, biostructural patholog, in silico drug desin,  ADME-Tox prediction,  low-molecular modulators of protein-protein interactions;

Over 100 research articles, reviews and book chapters;

3 patents, 1 sofware licence

Editor of the e-book "In silico lead discovery (Bentham Sci Piblishers)

Assoc. Editor for BMC Pharmacol & Toxicol

Image d’exemple